SOLESENCE INC
SLSNNASDAQTrading Snapshot
- Day Range
- $0.81 β $0.82
- 52-Week Range
- $0.61 β $4.55
- Volume
- $2.87B
- Avg Volume
- $3.67B
- Shares Outstanding
- 70.6M
- Next Earnings
- Oct 31, 2026
Fundamentals Snapshot
- Annual Revenue
- $62M
- Last Q Revenue
- $15M
- P/E Ratio
- β
- P/S Ratio
- 1.1x
- EPS (TTM)
- $-0.03
- Dividend Yield
- β
- Dilution (1yr)
- +4.0%
Why Investors Own SLSN
- βHigh-growth profile β revenue up +47.2% YoY with expanding US Equity exposure.
- βHealthy economics β 55% gross margin and 6% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
SOLESENCE INC
SLSNAbout SOLESENCE INC
Solesence, Inc., formerly known as Nanophase Technologies Corporation, specializes in the development and production of clean-label, inclusive, and mineral-based skincare and cosmetic products. The company collaborates with a diverse range of partners, from major global corporations to independent brands, employing its unique Active Stress Defenseβ’ technology suite. Through this proprietary system, Solesence brings innovative beauty solutions to the market that provide effective environmental protection.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates

Analyzing FitLife Brands (NASDAQ:FTLF) and Solesence (NASDAQ:SLSN)
Solesence (NASDAQ: SLSN - Get Free Report) and FitLife Brands (NASDAQ: FTLF - Get Free Report) are both small-cap consumer staples companies, but which is the better business? We will contrast the two businesses based on

SLSN's Earnings Break-Even in Q2, High Operating Costs Hurt
Solesence's Q2 results are pressured by higher operating expenses, but improving production efficiency and expectations for a stronger second half provide reasons for optimism.

Solesence, Inc. (SLSN) Q2 2026 Earnings Call Transcript
Solesence, Inc. (SLSN) Q2 2026 Earnings Call Transcript

SolΓ©sence Reports Second Quarter 2026 Financial Results
Please call Alissa Nakamoto at 216-509-9062 to confirm the details of the release. Please ensure that the release has the same distributions as past PRs.

SolΓ©sence Reschedules Second Quarter 2026 Conference Call to August 19
ROMEOVILLE, Ill. , Aug. 10, 2026 (GLOBE NEWSWIRE) -- SolΓ©sence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company has

SolΓ©sence To Report Second Quarter 2026 Financial Results and Host a Conference Call on August 11
ROMEOVILLE, Ill., July 28, 2026 (GLOBE NEWSWIRE) -- SolΓ©sence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will